The A4 study: Stopping AD before symptoms begin?

Science Translational Medicine

Volumn 6, Issue 228, 2014, Pages

  Sperling, Reisa A ^a,b   Rentz, Dorene M ^a,b   Johnson, Keith A ^a,b   Karlawish, Jason ^c   Donohue, Michael ^d   Salmon, David P ^d   Aisen, Paul ^d  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID; AMYLOID BETA PROTEIN[1-42]; AMYLOID PRECURSOR PROTEIN; APOLIPOPROTEIN E4; FLORBETAPIR F 18; PLACEBO; PRESENILIN 1; PRESENILIN 2; SOLANEZUMAB; TAU PROTEIN;

ALZHEIMER DISEASE; AMYLOID PLAQUE; ARTICLE; CLINICAL DEMENTIA RATING; GENE MUTATION; GENETIC RISK; HOMOZYGOTE; HUMAN; MILD COGNITIVE IMPAIRMENT; NERVE DEGENERATION; NEUROFIBRILLARY TANGLE; NEUROPSYCHOLOGICAL TEST; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SECONDARY PREVENTION; ANTAGONISTS AND INHIBITORS; METABOLISM; PATHOPHYSIOLOGY;

ALZHEIMER DISEASE; AMYLOID; HUMANS;

EID: 84899047367     PISSN: 19466234     EISSN: 19466242     Source Type: Journal    
DOI: 10.1126/scitranslmed.3007941     Document Type: Article

References (10)

1. R. A. Sperling, P. S. Aisen, L. A. Beckett, D. A. Bennett, S. Craft, A. M. Fagan, T. Iwatsubo, C. R. Jack Jr., J. Kaye, T. J. Montine, D. C. Park, E. M. Reiman, C. C. Rowe, E. Siemers, Y. Stern, K. Yaffe, M. C. Carrillo, B. Thies, M. Morrison-Bogorad, M. V. Wagster, C. H. Phelps, Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 7, 280-292 (2011).
2. R. J. Bateman, C. Xiong, T. L. Benzinger, A. M. Fagan, A. Goate, N. C. Fox, D. S. Marcus, N. J. Cairns, X. Xie, T. M. Blazey, D. M. Holtzman, A. Santacruz, V. Buckles, A. Oliver, K. Moulder, P. S. Aisen, B. Ghetti, W. E. Klunk, E. McDade, R. N. Martins, C. L. Masters, R. Mayeux, J. M. Ringman, M. N. Rossor, P. R. Schofield, R. A. Sperling, S. Salloway, J. C. Morris, Dominantly Inherited Alzheimer Network, Clinical and biomarker changes in dominantly inherited Alzheimer's disease. N. Engl. J. Med. 367, 795-804 (2012).
3. E. M. Reiman, Y. T. Quiroz, A. S. Fleisher, K. Chen, C. Velez-Pardo, M. Jimenez-Del-Rio, A. M. Fagan, A. R. Shah, S. Alvarez, A. Arbelaez, M. Giraldo, N. Acosta-Baena, R. A. Sperling, B. Dickerson, C. E. Stern, V. Tirado, C. Munoz, R. A. Reiman, M. J. Huentelman, G. E. Alexander, J. B. Langbaum, K. S. Kosik, P. N. Tariot, F. Lopera, Brain imaging and fluid biomarker analysis in young adults at genetic risk for autosomal dominant Alzheimer's disease in the presenilin 1 E280A kindred: A case-control study. Lancet Neurol. 11, 1048-1056 (2012).
4. R. A. Sperling, C. R. Jack Jr., P. S. Aisen, Testing the right target and right drug at the right stage. Sci. Transl. Med. 3, 111cm33 (2011).
5. J. D. Grill, J. Karlawish, D. Elashoff, B. G. Vickrey, Risk disclosure and preclinical Alzheimer's disease clinical trial enrollment. Alzheimers Dement. 9, 356-359, e1 (2013).
6. E. Grober, C. B. Hall, R. B. Lipton, A. B. Zonderman, S. M. Resnick, C. Kawas, Memory impairment, executive dysfunction, and intellectual decline in preclinical Alzheimer's disease. J. Int. Neuropsychol. Soc. 14, 266-278 (2008).
7. D. M. Rentz, R. E. Amariglio, J. A. Becker, M. Frey, L. E. Olson, K. Frishe, J. Carmasin, J. E. Maye, K. A. Johnson, R. A. Sperling, Face-name associative memory performance is related to amyloid burden in normal elderly. Neuropsychologia 49, 2776-2783 (2011).
8. S. M. Stark, M. A. Yassa, C. E. Stark, Individual differences in spatial pattern separation performance associated with healthy aging in humans. Learn. Mem. 17, 284-288 (2010).
9. N. Kozauer, R. Katz, Regulatory innovation and drug development for early-stage Alzheimer's disease. N. Engl. J. Med. 368, 1169-1171 (2013).
10. F. Taylor, K. Ward, T. H. Moore, M. Burke, G. Davey Smith, J. P. Casas, S. Ebrahim, Statins for the primary prevention of cardiovascular disease. Cochrane Database Syst. Rev. (1): CD004816 (2011).